BCTG ACQUISITION CORP filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by BCTG ACQUISITION CORP (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-04-08Southpoint Capital Advisors LPTango Therapeutics, Inc.5,276,6994.9%EDGAR
SC 13G/A2024-02-14Southpoint Capital Advisors LPTango Therapeutics, Inc.5,276,6995.2%EDGAR
SC 13G/A2024-02-13GILEAD SCIENCES, INC.Tango Therapeutics, Inc.4,854,4434.8%EDGAR
SC 13G/A2024-02-09FMR LLCTango Therapeutics, Inc.9,787,3509.6%EDGAR
SC 13D/A2023-10-18BCTG Holdings, LLCTango Therapeutics, Inc.6,988,4506.9%EDGAR
SC 13G/A2023-10-16EcoR1 Capital, LLCTango Therapeutics, Inc.13,330,73613.1%EDGAR
SC 13G2023-09-21EcoR1 Capital, LLCTango Therapeutics, Inc.7,827,6367.7%EDGAR
SC 13G/A2023-09-11FMR LLCTango Therapeutics, Inc.13,548,07213.3%EDGAR
SC 13G2023-08-21Nextech Crossover I GP S.a r.l.Tango Therapeutics, Inc.5,533,9805.4%EDGAR
SC 13D/A2023-08-16BCTG Holdings, LLCTango Therapeutics, Inc.6,988,4506.9%EDGAR
SC 13G/A2023-02-14Casdin Capital, LLCTango Therapeutics, Inc.00.0%EDGAR
SC 13G/A2023-02-14Cormorant Asset Management, LPTango Therapeutics, Inc.1,000,000-EDGAR
SC 13G/A2023-02-09FMR LLCTango Therapeutics, Inc.9,083,6798.3%EDGAR
SC 13G2022-07-11Southpoint Capital Advisors LPTango Therapeutics, Inc.4,500,0005.1%EDGAR
SC 13G/A2022-02-14RA CAPITAL MANAGEMENT, L.P.Tango Therapeutics, Inc.2,250,0002.6%EDGAR
SC 13G2022-02-14Cormorant Asset Management, LPTango Therapeutics, Inc.4,899,184-EDGAR
SC 13G/A2022-02-10Southpoint Capital Advisors LPTango Therapeutics, Inc.3,000,0003.4%EDGAR
SC 13G2022-02-09FMR LLCTango Therapeutics, Inc.7,182,1886.6%EDGAR
SC 13D/A2022-01-04BCTG Holdings, LLCTango Therapeutics, Inc.6,988,4508.0%EDGAR
SC 13G2021-09-10GILEAD SCIENCES INCTango Therapeutics, Inc.4,854,4435.5%EDGAR
External links